Hôpital Pitié Salpêtrière - AP-HP

85 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Liver and bile duct cancer #NCT05528952
Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A None Systemic Treatment-Naive
Immunotherapy
Hôpital Pitié Salpêtrière - AP-HP (Paris)
CHU de Besançon
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT04617756
Upper excretory tract cancer Urothelial carcinoma Localized None Systemic Treatment-Naive
Surgery
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Centre Hospitalier Universitaire de Nîmes
Phase 1 / Phase 2 Breast cancer #NCT05386108 #2024-512878-98-00
Phase 2
HER2 Negative HR Positive Metastatic 1 2 3 or more Chemotherapy Targeted therapy Hormone therapy
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Stemline Therapeutics, Inc.
Phase 1 / Phase 2 Stomach and esophageal cancer #NCT06445972 #2023-509306-29-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic 1 Chemotherapy
HER2 Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Stomach and esophageal cancer #NCT06469944 #2023-509307-33-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
HER2 Immunotherapy Antibody Drug Conjugates (ADC)
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Parties A1, A2, A3 (escalade de dose)
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Endometrial cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B3
Locally Advanced Metastatic ATM 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B4
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B1
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B5
Adenocarcinoma Metastatic ATM 2
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Artios Pharma Ltd